Impact Of BCR-ABL1 Monitoring Among Patients With BCR-ABL1-Positive B-Acute Lymphoblastic Leukemia
Acute lymphoblastic leukaemia (ALL) with BCR-ABL1 confers a high risk of relapse and a poor prognosis. Access to the tyrosine kinase inhibitor as part of the treatment strategy has changed the risk stratification for ALL patients harbouring this fusion gene. As BCR-ABL1 is routinely quantified for t...
Saved in:
相似書籍
-
Detection of the BCR-ABL rearrangements by molecular analysis in acute lymphoblastic leukaemia (ALL) patients in Malaysia /
由: Tan, Christina San San
出版: (1996) -
Detection of T3151 mutated BCR-ABL in chronic myeloid leukemia patients diagnosed in UKMMC /
由: Mardziah Mohamad
出版: (2016) -
Interpatient variation of clinical responses among acute lymphoblastic leukaemia (all) patients treated with 6-mercatopurine (6-MP): a pharmacogenomics - metabolomics perspective / Wan Rosalina Wan Rosli
由: Wan Rosli, Wan Rosalina
出版: (2011) -
Synthesis, characterization and anticancer study of some transition metal complexes of flexidentate schiff base ligands derived from indole-7-Thiosemicarbazone/Thiocarbohydrazone /
由: Ibrahim, Abeer Abdul Jaleel
出版: (2014) -
Effects of disrupting insulin-like growth factor-1 receptor (IGF-1R) signal transduction pathways with inhibitors of IGF-1R, EGFR, PI3K, MEK, and MTOR in breast cancer cell lines
由: Ayub, Ayunadirah
出版: (2014)